Cytokine regulation of hepatic stellate cells in liver fibrosis

Alcoholism: Clinical and Experimental Research

Volumn 23, Issue 5, 1999, Pages 911-916

  Tsukamoto, Hidekazu ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chemokines; Fibrogenesis; Ito Cells; Myofibroblastic Activation

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; MATRIX PROTEIN; PLATELET DERIVED GROWTH FACTOR; RETINOL; SOMATOMEDIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CELL MIGRATION; CELL PROLIFERATION; CONFERENCE PAPER; FIBROGENESIS; HUMAN; HUMAN CELL; LIVER FIBROSIS; MITOGENESIS; PRIORITY JOURNAL; STELLATE CELL;

EID: 0033060611     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1999.tb04202.x     Document Type: Conference Paper

References (61)

1. Bissell DM: Connective tissue metabolism and hepatic fibrosis: An overview. Semin Liver Dis 10:iii-iiv, 1990.
2. Friedman SL: The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328:1828-1835, 1993.
3. Gressner AM: Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J Hepatol 22(Suppl. 2):28-36, 1995.
4. Pinzani M, Gesualdo L, Sabbah GM, Abboud HE: Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 84:1786-1793, 1989.
5. Matsuoka M, Pham NT, Tsukamoto H: Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor-β1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver 9:71-78, 1989.
6. Weiner FR, Giambrone MA, Czaja MJ, et al: Ito-cell gene expression and collagen regulation. Hepatology 11:111-117, 1990.
7. Armendariz-Borunda J, Katayama K, Seyer JM: Transcriptional mechanisms of type I collagen gene expression are differentially regulated by interleukin-1β, tumor necrosis factor alpha, and transforming growth factor beta in Ito cells. J Biol Chem 267:14316-14321, 1992.
8. Bachem MG, Sell KM, Melchior R, Kropf J, Eller T, Gressner AM: Tumor necrosis factor alpha (TNF alpha) and transforming growth factor-β1 (TGF beta 1) stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblasts. Virchows Arch B Cell Pathol 63:123-130, 1993.
9. Friedman SL, Wei S, Blaner WS: Retinol release by activated rat hepatic lipocytes: Regulation by Kupffer cell-conditioned medium and PDGF. Am J Physiol 264(Gastrointest Liver Physiol 27):G947-G952, 1993.
10. David BH: Transforming growth factor-β1 responsiveness is modulated by the extracellular collagen matrix during hepatic Ito cell culture. J Cell Physiol 136:547-553, 1988.
11. Poulos JE, Weber JD, Bellezzo JM, Di Bisceglie AM, Britton RS, Bacon BR, Baldassare JJ: Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells. Am J Physiol 273(Gastrointest Liver Physiol 36):G804-G811, 1997.
12. Carloni V, Romanelli RG, Pinzani M, Laffi G, Gentilini P: Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. Gastroenterology 112:522-531, 1997.
13. Iredale JP, Goddard S, Murphy G, Benyon RC, Arthur MJP: Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci (Colch) 89:75-81, 1995.
14. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G: Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103-111, 1993.
15. Rockey DC, Housset CN, Friedman SL: Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest 92:1795-1804, 1993.
16. Rockey DC, Chung JJ: Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing. J Clin Invest 98:1381-1388, 1996.
17. Hines JE, Johnson SJ, Burt AD: In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. Am J Pathol 142:511-518, 1993.
18. Matsuoka M, Tsukamoto H: Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: Implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 11:599-605, 1990.
19. Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeirsson SS: Cellular distribution of transforming growth factor-β1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 85:1833-1843, 1990.
20. Bissell DM, Wang SS, Jarnagin WR, Roll FJ: Cell-specific expression of transforming growth factor-β in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 96:447-455, 1995.
21. Hisama N, Yamaguchi Y, Miyanari N, Ichiguchi O, Goto M, Mori K, Ogawa M: Ischemia-reperfusion injury: The role of Kupffer cells in the production of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family. Transplant Proc 27:1604-1606, 1995.
22. Knolle PA, Loser E, Protzer U, Duchmann R, Schmitt E, zum Büschenfekde KH, Rose-John S, Gerken G: Regulation of endotoxin-induced IL-6 production in liver sinusoidal endothelial cells and Kupffer cells by IL-10. Clin Exp Immunol 107:555-561, 1997.
23. Knolle PA, Uhrig A, Protzer U, Trippler M, Duchmann R, zum Büshenfelde KH, Gerken G: Interleukin-10 expression is autoregulated at the transcriptional level in human and murine Kupffer cells. Hepatology 27:93-99, 1998.
24. Bachem MG, Meyer D, Melchior R, Sell KM, Gressner AM: Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblast-like cells. A potential mechanism of self-perpetuation in liver fibrogenesis. J Clin Invest 89:19-27, 1992.
25. Tramas EG, Symeonidis A: Morphologic and functional changes in the livers of rats after ligation and excision of the common bile duct. Am J Pathol 33:13-27, 1957.
26. Pinzani M, Abboud HE, Aron DC: Secretion of insulin-like growth factor-I and binding proteins by rat liver fat-storing cells: Regulatory role of platelet-derived growth factor. Endocrinology 127:2343-2349, 1990.
27. Evarts RP, Hu Z, Fujio K, Marsden ER, Thorgeirsson SS: Activation of hepatic stem cell compartment in the rat: Role of transforming growth factor α, hepatocyte growth factor, and acidic fibroblast growth factor in early proliferation. Cell Growth Different 4:555-561, 1993.
28. 1 in cultured hepatic stellate cells. Endocrinology 138:4683-4689, 1997.
29. Maher JJ: Cell-specific expression of hepatocyte growth factor in liver. J Clin Invest 91:2244-2252, 1993.
30. Marsden ER, Hu Z, Fujio K, Nakatsukasa H, Thorgeirsson SS, Evarts RP: Expression of acidic fibroblast growth factor in regenerating liver and during hepatic differentiation. Lab Invest 67:427-433, 1992.
31. Feder LS, Todaro JA, Laskin DL: Characterization of interleukin-1 and interleukin-6 production by hepatic endothelial cells and macrophages. J Leukoc Biol 53:126-132, 1993.
32. Harada K, Terada T, Nakanuma Y: Detection of transforming growth factor-alpha protein and messenger RNA in hepatobiliary diseases by immunohistochemical and in situ hybridization techniques. Hum Pathol 27:787-792, 1996.
33. Morland CM, Fear J, McNab G, Joplin R, Adams DH: Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. Proc Assoc Am Physicians 109:372-382, 1997.
34. Yasoshima M, Kono N, Sugawara H, Katayanagi K, Harada K, Nakanuma Y: Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial: In situ and culture study. Lab Invest 78:89-100, 1998.
35. Rockey DC, Maher JJ, Jarnagin WR, Gabbiani G, Friedman SL: Inhibition of rat hepatic lipocyte activation in culture by interferon-r Hepatology 16:776-784, 1992.
36. Rockey DC, Chung JJ: Interferon-γ inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: Implications for treatment of hepatic fibrosis. J Invest Med 42:660-670, 1994.
37. Rockey DC: Cytokine regulation of hepatic fibrogenesis, in Arroyo V, Bosch J, Bruguera M, Rodés J (eds): Therapy in Liver Diseases: The Pathophysiological Basis of Therapy. New York, Masson, SA, 1997, pp 179-184.
38. Wang SC, Ohata M, Schrum L, Rippe RA, Tsukamoto H: Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem 273:302-308, 1998.
39. Thompson KC, Millward-Sadler GH, Gentry J, Sheron N: Transgenic Il-10 deleted mice develop increased fibrosis in a carbon tetrachloride-induced model of hepatic cirrhosis (abstr). Hepatology 26: 335A, 1997.
40. Tsukamoto H, Home W, Kamimura S, et al. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96:620-630, 1995.
41. Tsukamoto H, Lin M, Pham TV, Nanji A, Fong TL: Role of inflammation in liver fibrogenesis, in Arroyo V, Bosch J, Bruguera M, Rodés J (eds): Therapy in Liver Diseases: The Pathophysiological Basis of Therapy. New York, Masson, SA, 1997, pp 173-178.
42. Lin M, Rippe RA, Niemelä O, Brittenham G, Tsukamoto H: Role of iron in NF-κB activation and cytokine gene expression by rat hepatic macrophages. Am J Physiol 272(Gastrointest Liver Physiol 35):G1355-G1364, 1997.
43. Lin M, Yin W, Wang SC, Ohata M, Pham T-V, Brittenham G, Tsukamoto H: Iron dependency of Kupffer cell NF-κB activation and cytokine expression in experimental ALD (abstr). Hepatology 24:185A, 1996.
44. Lin M, Giulivi C, Ohata M, Brittenham G, Tsukamoto H: Iron dependent NF-κB activation by hepatic macrophages. Hepatology 28: 440A, 1998.
45. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS: Hepatic expression of mature transforming growth factor-β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92:2572-2576, 1995.
46. Cloutheir DE, Comerford SA, Hammer RE: Hepatic fibrosis, glomerulosclerosis, and lipodystrophy-like syndrome in PEPCK-TGF-betal transgenic mice. J Clin Invest 100:2697-2713, 1997.
47. Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB: Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: A self-regulation system. J Cell Biol 111:757-763, 1990.
48. 4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-β in cocultures with sinusoidal endothelial cells. Hepatology 21:1429-1437, 1995.
49. Kojima S, Nara K, Rifkin DB: Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Biol 121:439-448, 1993.
50. Okuno M, Moriwaki H, Imai S, Muto Y, Kawada N, Suzuki Y, Kojima S: Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-β in liver stellate cells. Hepatology 26:913-921, 1997.
51. Davis BH, Kramer RT, Davidson NO: Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor β production. J Clin Invest 86:2062-2070, 1990.
52. Sato T, Kato R, Tyson CA: Regulation of differentiated phenotype of rat hepatic lipocytes by retinoids in primary culture. Exp Cell Res 217:72-83, 1995.
53. Knittel T, Fellmer P, Ramadori G: Gene expression and regulation of plasminogen activator inhibitor type I in hepatic stellate cells of rat liver. Gastroenterology 111:745-754, 1996.
54. Bissell DM, Wang SS, Jarnagin WR, Roll FJ: Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 96:447-455, 1995.
55. De Bleser PJ, Niki T, Rogiers V, Geerts A: Transforming growth factor-beta gene expression in normal and fibrotic rat liver. J Hepatol 26:886-893, 1997.
56. Roth S, Michel K, Gressner AM: (Latent) transforming growth factor β in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells. Hepatology 27:1003-1012, 1998.
57. Pinzani M, Abboud HE, Gesualdo L, Abboud SL: Regulation of macrophage colony-stimulating factor in liver fat-storing cells by peptide growth factors. Am J Physiol 261:C876-C881, 1992.
58. Pinzani M, Carloni V, Marra F, Riccardi D, Laffi G, Gentilini P: Biosynthesis of platelet-activating factor and its 10-acyl analogue by liver fat-storing cells. Gastroenterology 106:1301-1311, 1994.
59. Marra F, Valente AJ, Pinzani M, Abboud HE: Cultured human liver fat-storing cells produce monocyte chemotactic protein-1: Regulation by proinflammatory cytokines. J Clin Invest 92:1674-1680, 1993.
60. Maher JJ, Lozier JS, Scott MK: Rat hepatic stellate cells produce cytokine-induced neutrophil chemoattractants in culture and in vivo. Am J Physiol 275(Gastrointest Liver Physiol 38):G847-G853, 1998.
61. Hellerbrand C, Wang SC, Tsukamoto H, Brenner DA, Rippe RA: Expression of intercellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology 24:670-676, 1996.